Ind-Swift Laboratories Limited has announced the opening of a special window for re-lodgement of transfer requests of physical shares and dematerialisation, in compliance with SEBI regulations. The pharmaceutical company published newspaper advertisements on April 5, 2026, informing shareholders about this important facility.

Regulatory Compliance and Timeline

The special window has been established pursuant to SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026. This initiative aims to facilitate investors in gaining rightful access to their securities that were traded in physical form.

Shareholder Assistance and Process

Eligible shareholders seeking to utilise this facility can contact the company through multiple channels for assistance within the stipulated timeframe. The company has designated specific contact points to ensure smooth processing of requests.

Contact Information

Registrar and Share Transfer Agent (RTA):

• Email: rta@alankit.com
• Office: Alankit House, 4E/2 Jhandewalan Extension, New Delhi - 110 055
• Phone: 011-42541234

Company Direct Contact:

• Email: investor@indswiftlabs.com

Transfer Requirements and Documentation

Shareholders must fulfil specific requirements when lodging transfer requests with the RTA. The process has been designed to ensure compliance with current regulations while facilitating smooth conversion to dematerialised form.

Mandatory Requirements:

• Active demat account
• Client Master List (CML)
• Original transfer documents
• Physical share certificates

All transferred shares will be issued exclusively in dematerialised form once the RTA verifies and approves all submitted documents.

Newspaper Publication Details

The company fulfilled its regulatory obligations under Regulation 47 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, by publishing advertisements in leading newspapers.

This special window represents an important opportunity for shareholders holding physical securities to convert them to dematerialised form, ensuring better liquidity and easier transfer processes in line with current market practices.

Ind-Swift Laboratories Limited has submitted its mandatory compliance certificate under SEBI regulations for the quarter ended 31st March, 2026. The pharmaceutical company filed the certificate with BSE Limited and National Stock Exchange of India Limited on 3rd April, 2026, fulfilling its regulatory obligations under SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Filing

The compliance certificate was issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Pardeep Verma, VP-Corporate Affairs and Company Secretary of Ind-Swift Laboratories Limited, submitted the certificate to both stock exchanges where the company's shares are listed.

Certificate Confirmation

Alankit Assignments Limited, serving as the Registrar and Share Transfer Agent for Ind-Swift Laboratories Limited, issued the compliance certificate dated 1st April, 2026. The certificate was signed by Kamal Garg, General Manager at Alankit Assignments Limited.

The compliance certificate confirms two critical aspects of the dematerialization process:

• The securities comprised in the certificates have been listed on the Stock Exchanges
• The certificates after due verification have been mutilated and cancelled, with the name of depository substituted in records as registered owner

Company Information

Ind-Swift Laboratories Limited operates from its registered office located at SCO 850, Shivalik Enclave, NAC Manimajra, Sector 13, Chandigarh. The company maintains two manufacturing facilities - Unit I at NH-21, Village Jawaharpur, Tehsil Derabassi, District SAS Nagar (Mohali), Punjab, and Unit II at Phase 1, SIDCO Industrial Growth Centre, Samba, Jammu & Kashmir.

Regulatory Framework

The filing represents compliance with SEBI's mandatory requirements for companies whose shares are held in dematerialized form. Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 mandates that registrar and transfer agents provide quarterly certificates confirming proper handling of physical share certificates received for dematerialization.

This quarterly compliance filing demonstrates Ind-Swift Laboratories Limited's adherence to regulatory requirements and proper maintenance of shareholder records through its appointed registrar and transfer agent.